The Attorney General's office in Florida is looking into allegations of Enbrel-related marketing shenanigans at Amgen, but hasn't launched a formal investigation. The Senate Finance Committee and the New Jersey AG already are probing the allegations, made by two former sales reps in arbitration with the company. Report